Effect of continuous positive airway pressure therapy on cardiovascular risk factors in patients with type 2 diabetes and obstructive sleep apnea

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 11, 2012, Pages 4212-4218

  Myhill, Paul C ^a   Davis, Wendy A ^a   Peters, Kirsten E ^a   Chubb, S A Paul ^a,c   Hillman, David ^b   Davis, Timothy M E ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^c PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; LIPID; ORAL ANTIDIABETIC AGENT;

AGE DISTRIBUTION; AGED; APNEA HYPOPNEA INDEX; ARTICLE; AUSTRALIA; AUSTRALIAN; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; COHORT ANALYSIS; COMMUNITY LIVING; CONTROLLED STUDY; DIABETES MELLITUS; DIET THERAPY; DISEASE DURATION; EPWORTH SLEEPINESS SCALE; ETHNIC GROUP; FEMALE; GLYCEMIC CONTROL; HUMAN; LIFESTYLE MODIFICATION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PARALLEL DESIGN; PATIENT ATTITUDE; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSE RATE; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SLEEP DISORDERED BREATHING; THERAPY EFFECT; TREATMENT DURATION; URBAN POPULATION;

AGED; AGED, 80 AND OVER; AUSTRALIA; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CONTINUOUS POSITIVE AIRWAY PRESSURE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; POLYSOMNOGRAPHY; QUALITY OF LIFE; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; TREATMENT OUTCOME;

EID: 84868628543     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-2107     Document Type: Article

References (41)

1. Babu AR, Herdegen J, Fogelfeld L, Shott S, Mazzone T 2005 Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med 165:447-452 (Pubitemid 40280202)
2. Pillai A, Warren G, Gunathilake W, Idris I 2011 Effects of sleep apnea severity on glycemic control in patients with type 2 diabetes prior to continuous positive airway pressure treatment. Diabetes Technol Ther 13:945-949
3. Hassaballa HA, Tulaimat A, Herdegen JJ, Mokhlesi B 2005 The effect of continuous positive airway pressure on glucose control in diabetic patients with severe obstructive sleep apnea. Sleep Breath 9:176-180 (Pubitemid 44184314)
4. West SD, Nicoll DJ, Wallace TM, Matthews DR, Stradling JR 2007 Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax 62:969-974 (Pubitemid 350084496)
5. Sharma SK, Agrawal S, Damodaran D, Sreenivas V, Kadhiravan T, Lakshmy R, Jagia P, Kumar A 2011 CPAP for the metabolic syndrome in patients with obstructive sleep apnea. N Engl J Med 365: 2277-2286
6. Coughlin SR, Mawdsley L, Mugarza JA, Wilding JP, Calverley PM 2007 Cardiovascular and metabolic effects of CPAP in obese males with OSA. Eur Respir J 29:720-727 (Pubitemid 46554622)
7. Smurra M, Philip P, Taillard J, Guilleminault C, Bioulac B, Gin H 2001 CPAP treatment does not affect glucose-insulin metabolism in sleep apneic patients. Sleep Med 2:207-213 (Pubitemid 34846769)
8. Faccenda JF, Mackay TW, Boon NA, Douglas NJ 2001 Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 163:344-348 (Pubitemid 32158510)
9. Kohler M, Pepperell JC, Casadei B, Craig S, Crosthwaite N, Stradling JR, Davies RJ 2008 CPAP and measures of cardiovascular risk in males with OSAS. Eur Respir J 32:1488-1496
10. Durán-Cantolla J, Aizpuru F, Montserrat JM, Ballester E, Terán-Santos J, Aguirregomoscorta JI, Gonzalez M, Lloberes P, Masa JF, De La Peña M, Carrizo S, Mayos M, Barbé F 2010 Continuous positive airway pressure as treatment for systemic hypertension in people with obstructive sleep apnoea: randomised controlled trial. BMJ 341:c5991
11. Hedner J, Darpö B, Ejnell H, Carlson J, Caidahl K 1995 Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications. Eur Respir J 8:222-229
12. Robinson GV, Smith DM, Langford BA, Davies RJ, Stradling JR 2006 Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients. Eur Respir J 27:1229-1235 (Pubitemid 44914309)
13. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, Mullins R, Jenkinson C, Stradling JR, Davies RJ 2002 Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 359:204-210 (Pubitemid 34113817)
14. Robinson GV, Pepperell JC, Segal HC, Davies RJ, Stradling JR 2004 Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. Thorax 59:777-782 (Pubitemid 39215375)
15. Shaw JE, Punjabi NM, Wilding JP, Alberti KG, Zimmet PZ 2008 Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention. Diabetes Res Clin Pract 81:2-12 (Pubitemid 351778429)
16. Balk EM, Chung M, Chan JA, Moorthy D, Patel K, Concannon TW, Ratichek SJ, Chang LKW 2012 Future research needs for treatment of obstructive sleep apnea: identification of future research needs from Comparative Effectiveness Review No 32. Rockville, MD: Agency for Healthcare Research and Quality
17. Davis TM, Bruce DG, Davis WA 28 April 2012 Cohort profile: the Fremantle Diabetes Study (FDS). Int J Epidemiol 10.1093/ije/dys065
18. Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP 1999 Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 131:485-491 (Pubitemid 29482391)
19. Brown DL, Anderson CS, Chervin RD, Kushida CA, Lewin DS, Malow BA, Redline S, Goldman EB 2011 Ethical issues in the conduct of clinical trials in obstructive sleep apnea. J Clin Sleep Med 7:103-108
20. Jenkinson C, Davies RJ, Mullins R, Stradling JR 1999 Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet 353:2100-2105 (Pubitemid 29278478)
21. Young T, Evans L, Finn L, Palta M 1997 Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women. Sleep 20:705-706 (Pubitemid 27506200)
22. Johns MW 1991 A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14:540-545
23. Anderson GM, Young JG, Jatlow PI, Cohen DJ 1981 Urinary free catecholamines determined by liquid chromatography-fluorometry. Clin Chem 27:2060-2063 (Pubitemid 12194444)
24. Division of Metabolism and Endocrinology Products 2008 Guidance for industry. Diabetes mellitus: developing drugs and therapeutic biologics for treatment and prevention. Rockville, MD: U.S. Department of Health and Human Services Food and Drug Administration
25. Davis WA, Bruce DG, Davis TM 2006 Is self-monitoring of blood glucose appropriate for all type 2 diabetic patients? The Fremantle Diabetes Study. Response to Kolb et al. (letter). Diabetes Care 30:184-185
26. Campbell NR, Gilbert RE, Leiter LA, Larochelle P, Tobe S, Chockalingam A, Ward R, Morris D, Tsuyuki RT, Harris SB 2011 Hypertension in people with type 2 diabetes: update on pharmacologic management. Can Family Physician 57:997-1002, e347-e353
27. Eguchi K, Pickering TG, Kario K 2007 Why is blood pressure so hard to control in patients with type 2 diabetes? J Cardiometab Syndr 2:114-118
28. American Diabetes Association 2012 Standards of medical care in diabetes: 2012. Diabetes Care 35(Suppl 1):S11-S63
29. Schrier RW, Estacio RO, Mehler PS, Hiatt WR 2007 Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial. Nat Clin Pract Nephrol 3:428-438 (Pubitemid 47123588)
30. Carlson JT, Hedner J, Elam M, Ejnell H, Sellgren J, Wallin BG 1993 Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest 103:1763-1768 (Pubitemid 23174312)
31. Elmasry A, Lindberg E, Hedner J, Janson C, Boman G 2002 Obstructive sleep apnoea and urine catecholamines in hypertensive males: a population-based study. Eur Respir J 19:511-517 (Pubitemid 34256968)
32. Lam JC, Lam B, Yao TJ, Lai AY, Ooi CG, Tam S, Lam KS, Ip MS 2010 A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoea. Eur Respir J 35:138-145
33. Goldstein DS 1983 Plasma catecholamines and essential hypertension. An analytical review. Hypertension 5:86-99 (Pubitemid 13179794)
34. Aboyans V, Criqui MH 2006 Can we improve cardiovascular risk prediction beyond risk equations in the physician's office? J Clin Epidemiol 59:547-558
35. Colagiuri S, Dickinson S, Girgis S, Colagiuri R 2009 National evidence based guideline for blood glucose control in type 2 diabetes. Canberra, Australia: Diabetes Australia and the National Health and Medical Research Council
36. Shpirer I, Rapoport MJ, Stav D, Elizur A 2012 Normal and elevated HbA1C levels correlate with severity of hypoxemia in patients with obstructive sleep apnea and decrease following CPAP treatment. Sleep Breath 16:461-466
37. Tonkin A, Barter P, Best J, Boyden A, Furler J, Hossack K, Sullivan D, Thompson P, Vale M, Cooper C, Robinson M, Clune E 2005 National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: position statement on lipid management: 2005. Heart Lung Circ 14:275-291
38. Vakulin A, Baulk SD, Catcheside PG, Antic NA, van den Heuvel CJ, Dorrian J, McEvoy RD 2011 Driving simulator performance remains impaired in patients with severe OSA after CPAP treatment. J Clin Sleep Med 7:246-253
39. Bradley TD, Floras JS 2009 Obstructive sleep apnoea and its cardiovascular consequences. Lancet 373:82-93
40. Angermayr L, Melchart D, Linde K 2010 Multifactorial lifestyle interventions in the primary and secondary prevention of cardiovascular disease and type 2 diabetes mellitus: a systematic review of randomized controlled trials. Ann Behav Med 40:49-64
41. O'Driscoll DM, Horne RS, Davey MJ, Hope SA, Anderson V, Trinder J, Walker AM, Nixon GM 2011 Increased sympathetic activity in children with obstructive sleep apnea: cardiovascular implications. Sleep Med 12:483-488